Regulatory Impact

Showing 1131 articles
Business

New Gold Shareholders Overwhelmingly Approve Coeur Mining Acquisition, Paving Way for Major North American Precious Metals Player

Shareholders of New Gold Inc. (TSX:NGD) and Coeur Mining, Inc. have given resounding approval to Coeur's plan to acquire all outstanding shares of New Gold. The vote clears a critical path for the merger, which now awaits final regulatory and court nods to create a significantly larger, diversified precious metals producer with enhanced scale and exploration prospects across North America.

Business

Ondas Secures Coveted Pentagon 'Blue List' Approval for Optimus Drone, Fueling Investor Debate on Valuation

Ondas Holdings' flagship Optimus drone system has received the Defense Contract Management Agency's critical 'Blue List' certification, clearing it for broader U.S. defense and national security deployment. The milestone has ignited a surge in the company's stock while prompting analysts to scrutinize its long-term path to converting regulatory approval into sustainable revenue.

Business

IDEXX Laboratories Posts Strong Q4 Growth, Unveils Ambitious 2026 Outlook on Diagnostic Innovation

IDEXX Laboratories (IDXX) reported robust double-digit growth for Q4 2025, driven by record placements of its premium diagnostic instruments and expanding test utilization. While acknowledging persistent softness in U.S. veterinary visit volumes, the company outlined a confident initial 2026 forecast, banking on its innovation pipeline and the transformative impact of its inVue Dx system.

World

France Tightens Toxin Rules, Sparking Fresh Infant Formula Recalls

Two French infant formula makers have recalled multiple product batches following the government's decision to slash permissible levels of cereulide, a toxin linked to gastrointestinal illness. The move amplifies a global safety crisis that has seen major brands issue recalls across dozens of countries since late last year.